Literature DB >> 31090959

Identification of a nuclear localization signal and importin beta members mediating NUAK1 nuclear import inhibited by oxidative stress.

Mario Palma1, Elizabeth N Riffo1, Tamaki Suganuma2, Michael P Washburn2,3, Jerry L Workman2, Roxana Pincheira1, Ariel F Castro1.   

Abstract

NUAK1 is a serine/threonine kinase member of the AMPK-α family. NUAK1 regulates several processes in tumorigenesis; however, its regulation and molecular targets are still poorly understood. Bioinformatics analysis predicted that the majority of NUAK1 localizes in the nucleus. However, there are no studies about the regulation of NUAK1 subcellular distribution. Here, we analyzed NUAK1 localization in several human cell lines, mouse embryo fibroblasts, and normal mouse tissues. We found that NUAK1 is located in the nucleus and also in the cytoplasm. Through bioinformatics analysis and studies comparing subcellular localization of wild type and NUAK1 mutants, we identified a conserved bipartite nuclear localization signal at the N-terminal domain of NUAK1. Based on mass spectrometry analysis, we found that NUAK1 interacts with importin-β members including importin-β1 (KPNB1), importin-7 (IPO7), and importin-9 (IPO9). We confirmed that importin-β members are responsible for NUAK1 nuclear import through the inhibition of importin-β by Importazole and the knockdown of either IPO7 or IPO9. In addition, we found that oxidative stress induces NUAK1 cytoplasmic accumulation, indicating that oxidative stress affects NUAK1 nuclear transport. Thus, our study is the first evidence of an active nuclear transport mechanism regulating NUAK1 subcellular localization. These data will lead to investigations of the molecular targets of NUAK1 according to its subcellular distribution, which could be new biomarkers or targets for cancer therapies.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  NUAK1; bipartite-NLS; importin-β; nuclear import; nuclear localization signal (NLS); oxidative stress

Year:  2019        PMID: 31090959     DOI: 10.1002/jcb.28890

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  5 in total

1.  Localized Inhibition of Protein Phosphatase 1 by NUAK1 Promotes Spliceosome Activity and Reveals a MYC-Sensitive Feedback Control of Transcription.

Authors:  Giacomo Cossa; Isabelle Roeschert; Florian Prinz; Apoorva Baluapuri; Raphael Silveira Vidal; Christina Schülein-Völk; Yun-Chien Chang; Carsten Patrick Ade; Guido Mastrobuoni; Cyrille Girard; Lars Wortmann; Susanne Walz; Reinhard Lührmann; Stefan Kempa; Bernhard Kuster; Elmar Wolf; Dominik Mumberg; Martin Eilers
Journal:  Mol Cell       Date:  2020-01-31       Impact factor: 17.970

2.  IPO7 promotes pancreatic cancer progression via regulating ERBB pathway.

Authors:  Ming Li; Dongqiang Xu; Yijun Zhan; Shiyun Tan
Journal:  Clinics (Sao Paulo)       Date:  2022-05-16       Impact factor: 2.898

3.  Yeast Nuak1 phosphorylates histone H3 threonine 11 in low glucose stress by the cooperation of AMPK and CK2 signaling.

Authors:  Seunghee Oh; Jaehyoun Lee; Selene K Swanson; Laurence Florens; Michael P Washburn; Jerry L Workman
Journal:  Elife       Date:  2020-12-29       Impact factor: 8.140

4.  KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway.

Authors:  Wenwen Du; Jianjie Zhu; Yuanyuan Zeng; Ting Liu; Yang Zhang; Tingting Cai; Yulong Fu; Weijie Zhang; Ruochen Zhang; Zeyi Liu; Jian-An Huang
Journal:  Cell Death Differ       Date:  2020-11-02       Impact factor: 15.828

5.  miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase.

Authors:  Francesca Maria Orlandella; Raffaela Mariarosaria Mariniello; Peppino Mirabelli; Anna Elisa De Stefano; Paola Lucia Chiara Iervolino; Vito Alessandro Lasorsa; Mario Capasso; Rosa Giannatiempo; Maria Rongo; Mariarosaria Incoronato; Francesco Messina; Marco Salvatore; Andrea Soricelli; Giuliana Salvatore
Journal:  Br J Cancer       Date:  2020-05-18       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.